Get in touch
CEPI is keen to discuss potential involvement with governments, funders, industry partners, academia, regulators, civil society organisations, and vaccine research groups. Please fill out the contact form below to get in touch with us.
Contact us
Get in touch
Press enquiries
If you have a press enquiry, please complete the contact form or email us directly at:
Speaker requests
To request the participation of a CEPI spokesperson at an event, please complete the following form:
Download and complete our Speaker request form(DOCX, 35.8 KB)
Send the completed form to [email protected]
Completed forms should be sent to [email protected]
A member of the CEPI team will review your request and if we are able to provide you with a relevant spokesperson we will be in touch to make further arrangements. Please note, CEPI receives a large volume of enquiries and whilst we always endeavour to fulfil speaker requests this won’t be possible on every occasion.
Latest News
Latest News
Richard Hatchett reflects on a “banner year for viruses” and looks ahead to 2025
In his end-of-year message, CEPI's CEO, Dr Richard Hatchett, reflects on a "banner year for viruses" and explores the trends, innovations and technologies that are shaping the future of global health.
Valneva expands access to Asia for its chikungunya vaccine with Serum
The collaboration to support broader vaccine access to the region falls within the agreement between Valneva and CEPI with co-funding from the EU.
Establishing vaccine safety benchmarking in Africa for African vaccines
Consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to understand prevalence of anticipated adverse events specifically relevant to African populations.
The Pneumoviruses and Adenoviruses
Among these viruses is a pervasive pathogen that infects nearly all babies and children worldwide at least once— sometimes twice—before they reach the age of two
Scientists launch largest-ever study tracking chikungunya burden in East Africa
Led by the University of Oxford, researchers are set to investigate the number of children and adults affected by chikungunya in Kenya and Tanzania.
Transatlantic scientists to transition traditional vaccine development onto rapid-response platform for faster outbreak control
Partnership could speed up parts of the vaccine development process by several months and save over £1 million in development costs
CEPI and Accumulus Synergy team up to enhance information equity and accelerate access to vaccines
Accumulus' cloud-based data-sharing platform could speed up access to vaccines and other health technologies by accelerating regulatory review.
Dr Amadou Sall to join CEPI as Executive Director of Manufacturing and Supply Chain
Dr Sall will join CEPI on 1 June 2025 upon completion of his tenure as CEO of Senegal’s Institut Pasteur de Dakar (IPD).
The Rhabdoviruses
The most fearsome Rhabdovirus causes a killer infection which makes its victims foam at the mouth
New project aims to bolster global vaccine preparedness against SARS-CoV-1 and SARS-CoV-2
Project will help to ensure the availability of antibody reagents for the development of vaccines against SARS-CoV-1 and SARS-CoV-2.
Latest News
Our locations
Oslo, Norway (HQ)
Visiting:
Skøyen Atrium, Askekroken 11, 0277 Oslo
Postal:
Postbox 1030 Hoff, 0218 Oslo
London, UK
CEPI, 6th floor, Henry Wood House, 4-5 Langham Place, London, W1B 3DG
Washington, USA
1901 Pennsylvania Ave, NW; Suite 1003; Washington, DC 20006; USA